These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 29121742

  • 1. Retinopathy and left ventricular hypertrophy in patients with chronic kidney disease: Interrelationship and impact on clinical outcomes.
    Kim Y, Cho JS, Cho WK, Yoon HE, Hong YA, Chang YK, Yang CW, Kim SY, Hwang HS.
    Int J Cardiol; 2017 Dec 15; 249():372-376. PubMed ID: 29121742
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of coexisting retinopathy and vascular calcification on chronic kidney disease progression and cardiovascular events.
    Hwang HS, Kim SY, Hong YA, Cho WK, Chang YK, Shin SJ, Yang CW, Kim SY, Yoon HE.
    Nutr Metab Cardiovasc Dis; 2016 Jul 15; 26(7):590-596. PubMed ID: 27089976
    [Abstract] [Full Text] [Related]

  • 3. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 4. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):45-52. PubMed ID: 29025789
    [Abstract] [Full Text] [Related]

  • 5. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
    Chang JM, Chen SC, Huang JC, Su HM, Chen HC.
    Am J Med Sci; 2014 Mar 06; 347(3):183-9. PubMed ID: 23426086
    [Abstract] [Full Text] [Related]

  • 6. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
    Ravera M, Noberasco G, Signori A, Re M, Filippi A, Cannavò R, Weiss U, Cricelli C, Deferrari G, Paoletti E.
    Am J Hypertens; 2013 May 06; 26(5):700-7. PubMed ID: 23391620
    [Abstract] [Full Text] [Related]

  • 7. The association between socioeconomic disparities and left ventricular hypertrophy in chronic kidney disease: results from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kang E, Lee J, Kim HJ, Han M, Kim SW, Lee KB, Sung S, Yoo TH, Chung W, Ahn C, Oh KH.
    BMC Nephrol; 2018 Aug 16; 19(1):203. PubMed ID: 30115015
    [Abstract] [Full Text] [Related]

  • 8. Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts.
    Hwang HS, Cho JS, Hong YA, Chang YK, Kim SY, Shin SJ, Yoon HE.
    Int J Med Sci; 2018 Aug 16; 15(6):557-563. PubMed ID: 29725245
    [Abstract] [Full Text] [Related]

  • 9. Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.
    Kabedi NN, Mwanza JC, Lepira FB, Kayembe TK, Kayembe DL.
    Cardiovasc J Afr; 2014 Aug 16; 25(5):228-32. PubMed ID: 25629539
    [Abstract] [Full Text] [Related]

  • 10. Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications.
    Calò LA, Vertolli U, Pagnin E, Ravarotto V, Davis PA, Lupia M, Naso E, Maiolino G, Naso A.
    Life Sci; 2016 Mar 01; 148():80-5. PubMed ID: 26872982
    [Abstract] [Full Text] [Related]

  • 11. Diabetes retinopathy is a poor predictor for renal and cardiovascular outcomes in comparison with hypertensive retinopathy in patients with chronic kidney disease.
    Hwang HS, Choi YA, Kim SY, Cho WK, Nam Y, Kim SJ, Yoon HE, Chang YK, Shin SJ, Yang CW, Kim SY.
    Diabetes Res Clin Pract; 2015 Aug 01; 109(2):312-8. PubMed ID: 26008724
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of combined target-organ damage in patients with essential hypertension.
    Carpinella G, Pagano G, Buono F, Petitto M, Guarino G, Orefice G, Rengo G, Trimarco B, Morisco C.
    Am J Hypertens; 2015 Jan 01; 28(1):127-34. PubMed ID: 24936579
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.
    Clin Exp Nephrol; 2019 Jan 01; 23(1):85-98. PubMed ID: 29951723
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease.
    Rudenko TE, Kamyshova ES, Vasilyeva MP, Bobkova IN, Solomakhina NI, Shvetsov MY.
    Ter Arkh; 2018 Sep 20; 90(9):60-67. PubMed ID: 30701737
    [Abstract] [Full Text] [Related]

  • 15. Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.
    Shi HT, Wang XJ, Li J, Song GF, Huang ZY, Guo XY, Guo JJ, Lv ZY, Li HW, Ge JB, Cui J, Qi GM.
    J Am Heart Assoc; 2015 Nov 09; 4(11):. PubMed ID: 26553212
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
    Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.
    Clin Exp Nephrol; 2013 Oct 09; 17(5):730-742. PubMed ID: 23318981
    [Abstract] [Full Text] [Related]

  • 17. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE, Kutyrina IM, Shvetsov MIu.
    Ter Arkh; 2012 Oct 09; 84(6):21-6. PubMed ID: 22997913
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
    Nardi E, Mulè G, Giammanco A, Mattina A, Geraci G, Nardi C, Averna M.
    Nutr Metab Cardiovasc Dis; 2021 Jan 04; 31(1):137-144. PubMed ID: 33092976
    [Abstract] [Full Text] [Related]

  • 19. Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.
    Kang E, Ryu H, Kim J, Lee J, Lee KB, Chae DW, Sung SA, Kim SW, Ahn C, Oh KH.
    J Am Heart Assoc; 2019 Sep 17; 8(18):e013357. PubMed ID: 31514574
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular hypertrophy among predialysis chronic kidney disease patients: Sindh institute of urology and transplantation experience.
    Ali T, Idrees MK, ShoukatDepartment of Nephrology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan., Akhtar SF.
    Saudi J Kidney Dis Transpl; 2017 Sep 17; 28(6):1375-1380. PubMed ID: 29265050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.